Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cost of Revenue: 2013-2020

Historic Cost of Revenue for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Dec 2020 value amounting to $897,000.

  • Ironwood Pharmaceuticals' Cost of Revenue fell 91.86% to $897,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $14.7 million, marking a year-over-year decrease of 38.62%. This contributed to the annual value of $3.1 million for FY2020, which is 86.86% down from last year.
  • As of Q4 2020, Ironwood Pharmaceuticals' Cost of Revenue stood at $897,000, which was down 59.94% from $2.2 million recorded in Q1 2020.
  • Ironwood Pharmaceuticals' 5-year Cost of Revenue high stood at $21.5 million for Q4 2018, and its period low was $506,000 during Q3 2019.
  • Over the past 3 years, Ironwood Pharmaceuticals' median Cost of Revenue value was $3.3 million (recorded in 2018), while the average stood at $6.0 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 390.96% in 2018, then tumbled by 91.86% in 2020.
  • Over the past 4 years, Ironwood Pharmaceuticals' Cost of Revenue (Quarterly) stood at $9.0 million in 2017, then soared by 138.90% to $21.5 million in 2018, then slumped by 48.69% to $11.0 million in 2019, then crashed by 91.86% to $897,000 in 2020.
  • Its Cost of Revenue was $897,000 in Q4 2020, compared to $2.2 million in Q1 2020 and $11.0 million in Q4 2019.